Meropenem response in neonatal carbapenem-resistant Klebsiella pneumoniae: a narrative review of in vitro-in vivo discordance [0.03%]
美罗培南在新生儿产超广谱β内酰胺酶克雷伯菌中的疗效：体外与体内不符的叙述性回顾文章
Matei Mselle,Vickfarajaeli Daudi
Matei Mselle
Background: Neonatal sepsis remains a major contributor to morbidity and mortality worldwide, particularly in low- and middle-income countries. gram-negative organisms, especially Klebsiella pneumoniae, are increasingly i...
Temporal trends in Group A Streptococcus epidemiology, antimicrobial susceptibility and emm-type distribution: a seven-year surveillance study from a UK district general hospital [0.03%]
2010—2016年英国教学医院A群链球菌的流行病学、抗菌药物敏感性及emm型分布特征调查
Pushpa Saajan,John Paul Candolesas,Shayi Shali et al.
Pushpa Saajan et al.
Background: Group A Streptococcus (GAS) remains universally susceptible to penicillin; however, resistance to macrolides and clindamycin varies geographically and may affect management, particularly in patients with penic...
Exploring the next "phage" of treating non-tuberculous mycobacterial infections [0.03%]
探索治疗非结核分枝杆菌感染的下一个“噬菌体”疗法阶段
Max Kevane-Campbell,Raja Idris,Silvia Würstle et al.
Max Kevane-Campbell et al.
Non-tuberculous mycobacteria (NTM) can present a serious clinical threat due to their resistance to conventional antibiotics and their ability to cause persistent infections. As antimicrobial resistance (AMR) represents one of the most sign...
Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer [0.03%]
一项抗菌药物管理干预措施对儿童癌症患者碳青霉烯类使用量的影响
Sarina K Butzer,Katrin Mehler,André Oberthuer et al.
Sarina K Butzer et al.
Purpose: Infections during neutropenia are a potentially life-threatening complication in pediatric oncology. International guidelines recommend antipseudomonal β-lactam monotherapy for stable patients, however, modi...
Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014-2020) [0.03%]
法国≥50岁成人呼吸道合胞病毒数据库和时间序列模型分析（2014-2020年）
Rachel M Reeves,Saskia Hagenaars,Rita Ammoun et al.
Rachel M Reeves et al.
Purpose: This study aimed to quantify the burden of respiratory syncytial virus (RSV)- and influenza-attributed acute respiratory infections (ARI) in older adults in France. Modelling was applied to real-world data on ARI...
Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis? [0.03%]
某非流行国家副肝吸虫病的少见临床表现及误诊病例报告
S Dirik,C Boesecke,S Breitschwerdt et al.
S Dirik et al.
Case presentation: We report a case of opisthorchiasis in a 71-year-old woman with intermittent upper abdominal pain, whose cause had remained unclear for a long time. She grew up in Kazakhstan and moved to Germany more t...
The evolution of sepsis care: from protocol-driven management to personalized intensive care [0.03%]
从基于协议的治疗到个体化的强化治疗：重症感染医学的发展趋势
Tim Rahmel,Benedikt H Siegler,Markus A Weigand et al.
Tim Rahmel et al.
Purpose: Sepsis remains one of the leading causes of morbidity and mortality worldwide. Despite evolving supportive therapeutic strategies, outcomes, particularly in severe disease manifestations, remain unsatisfactory. I...
Site-specific and time-varying Acinetobacter colonization and risk of invasive infection in critically ill patients [0.03%]
ICU病人不动杆菌的定点及时间定植及其侵袭性感染的风险
Alessandro Russo,Sara Palma Gullì,Eugenio Garofalo et al.
Alessandro Russo et al.
Purpose: Colonization by Acinetobacter baumannii is common among critically ill patients. However, the relative contribution of colonization at different anatomical sites and the impact of dynamic changes in colonization ...
vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective study [0.03%]
一项单中心回顾性研究：耐万古霉素肠球菌定植与急性髓系白血病患者强化化疗后总生存率下降有关
Sebastian Wolf,Nico Zeltner,Nele Henze et al.
Sebastian Wolf et al.
Background: Vancomycin-resistant enterococci (VRE) colonization is common among patients with acute myeloid leukemia (AML) undergoing intensive chemotherapy. Whether the teicoplanin-defined VRE phenotype, specifically van...
Seven versus fourteen days for resistant bloodstream infections: what do we actually know? A scoping review [0.03%]
七天与十四天？艰难梭菌感染后的导管相关性血流感染该如何抗感染治疗？系统综述
Valentina Zuccaro,Erika Asperges,Lea Nadia Marvulli et al.
Valentina Zuccaro et al.
Purpose: Recent randomized trials have established that 7 days of antibiotic therapy is noninferior to 14 days for bloodstream infections (BSI) caused by susceptible organisms. Whether this conclusion extends to BSI cause...